Followers | 141 |
Posts | 5891 |
Boards Moderated | 0 |
Alias Born | 10/27/2003 |

Thursday, August 16, 2018 8:34:33 PM
Artemis Resources Limited (“Artemis” or “the Company”) (ASX: ARV) is pleased to provide the following update by Novo Resources Corp. (“Novo”) on the Purdy’s Reward Conglomerate Gold Project. Novo is the manager of this project under the 50/50 Artemis – Novo Joint Venture arrangements. Purdy’s Reward is located south of Karratha in the Western Pilbara Region of Western Australia.
HIGHLIGHTS
* Ground disturbing exploration has restarted at Purdy’s Reward.
* Diamond drilling is underway and is aimed at further defining the prospective conglomerate gold unit along strike and down dip.
* Large area clearing for mapping (like that seen at Comet Well) to be undertaken, followed by bulk samples.
* Structural interpretation has identified faults which are formed during mineralisation.
Artemis’ Executive Director, Edward Mead, commented:
“We are pleased to see the resumption of exploration activities at Purdy’s Reward. The geological and structural understanding of the Comet Well to Purdy’s Reward Conglomerate gold trend has significantly advanced since exploration started. With bulk sampling techniques streamlined by Novo over the past months at Comet Well, Artemis looks forward to improved turn around times for assays from Purdy’s Reward.”
The relevant parts of the Novo news release (including figures) published on 16 August 2018 are shown below, with the addition of the JORC ‘Table 1’ appended to this release to comply with ASX requirements. Novo’s release can be read in full on its website. Artemis does not have an interest in the Comet Well tenement
www.artemisresources.com.au/investors-relations/announcements#
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM